- Home
- CRMT vs TLSI Comparison
CRMT vs TLSI Comparison
Compare CRMT & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMT
- TLSI
- Stock Information
- Founded
- CRMT 1981
- TLSI 2010
- Country
- CRMT United States
- TLSI United States
- Employees
- CRMT N/A
- TLSI N/A
- Industry
- CRMT Other Specialty Stores
- TLSI Medical Specialities
- Sector
- CRMT Consumer Discretionary
- TLSI Health Care
- Exchange
- CRMT Nasdaq
- TLSI Nasdaq
- Market Cap
- CRMT 266.5M
- TLSI 244.3M
- IPO Year
- CRMT N/A
- TLSI N/A
- Fundamental
- Price
- CRMT $27.04
- TLSI $4.73
- Analyst Decision
- CRMT Buy
- TLSI Strong Buy
- Analyst Count
- CRMT 1
- TLSI 4
- Target Price
- CRMT $45.00
- TLSI $11.13
- AVG Volume (30 Days)
- CRMT 188.3K
- TLSI 118.6K
- Earning Date
- CRMT 09-04-2025
- TLSI 11-13-2025
- Dividend Yield
- CRMT N/A
- TLSI N/A
- EPS Growth
- CRMT N/A
- TLSI N/A
- EPS
- CRMT 1.61
- TLSI N/A
- Revenue
- CRMT $1,378,681,000.00
- TLSI $35,990,000.00
- Revenue This Year
- CRMT $6.23
- TLSI $56.79
- Revenue Next Year
- CRMT $5.10
- TLSI $54.15
- P/E Ratio
- CRMT $16.74
- TLSI N/A
- Revenue Growth
- CRMT 0.64
- TLSI 45.50
- 52 Week Low
- CRMT $26.47
- TLSI $3.42
- 52 Week High
- CRMT $62.72
- TLSI $5.88
- Technical
- Relative Strength Index (RSI)
- CRMT 26.96
- TLSI 48.36
- Support Level
- CRMT $28.33
- TLSI $4.42
- Resistance Level
- CRMT $30.75
- TLSI $4.67
- Average True Range (ATR)
- CRMT 1.53
- TLSI 0.23
- MACD
- CRMT 0.06
- TLSI -0.03
- Stochastic Oscillator
- CRMT 7.63
- TLSI 61.87
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.